Table 3.
Recommended levels of HPV vaccination for general and special populations
| Crowd characteristics | Recommended level |
|---|---|
| General population | |
| 9–26 y female | Priority recommended |
| 27–45 y female | Recommended |
| Special population | |
| HPV infection/cytological abnormal | Recommended |
| Pregnancy woman | Not recommended |
| Lactation woman | Caution recommended |
| People with genetic susceptible population and high-risk population of cervical cancer | Priority recommended |
| People with immunodeficiency: | |
| HIV infection | Recommended |
| Autoimmune diseases: | Recommended |
| Systemic lupus erythematosus, | |
| Rheumatoid arthritis, | |
| Connective tissue disease, | |
| Sicca syndrome | |
| Sjogren's syndrome, | |
| Hashimoto's thyroiditis | |
| Diabetes (types I and II) | Recommended |
| Patients with renal failure and Hemodialysis | Discuss with your clinician |
| Patients taking long-term immunosuppressive drugs after organ/bone marrow transplantation | Discuss with your clinician |